Business · 30/03/2022Updated: 10/17/2026 · 1 min read
FDA Submits Proposed Information Collection for OMB Review
Summary
The Food and Drug Administration is requesting public comment on a proposed collection of information related to financial disclosure by clinical investigators, which has been submitted to the Office of Management and Budget for review and clearance under the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →